Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure
OA Location
Author(s)
Type
Journal Article
Date Issued
2017-04-01
ISSN
2213-1779
Publisher
ELSEVIER SCI LTD
Start Page
256
End Page
264
Journal / Book Title
JACC-HEART FAILURE
Volume
5
Issue
4
Sponsor
Royal Brompton & Harefield NHS Foundation Trust
National Institute for Health Research
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398335800003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
N/A
N/A
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
biomarkers
chronic ischemic heart disease
heart failure
inflammation
mortality
survival
ROSUVASTATIN MULTINATIONAL TRIAL
GISSI-HF TRIALS
STATIN THERAPY
CARDIOVASCULAR EVENTS
NATRIURETIC PEPTIDE
PREDICTIVE-VALUE
FATAL OUTCOMES
CORONA TRIAL
SOLUBLE ST2
URIC-ACID
CORONA Study Group
Publication Status
Published
